Literature DB >> 23652865

A case of macrophage activation syndrome developing in a patient with chronic granulomatous disease-associated colitis.

Kazuko Akagi1, Toshinao Kawai, Nobuyuki Watanabe, Midori Yokoyama, Katsuhiro Arai, Shizuko Harayama, Shinji Oana, Masafumi Onodera.   

Abstract

Although macrophage activation syndrome (MAS) develops in some patients with chronic granulomatous disease (CGD), all of the reported cases have been associated with pathogenic microbial infections. We report a 2-year-old boy with CGD-associated colitis who suffered from MAS without any clinical signs of a microbial infection. He was treated with 1 course of methylprednisolone pulse therapy and the clinical symptoms improved; however, the colitis was difficult to control even with immunosuppressive drugs, and he eventually required hematopoietic stem cell transplantation 1 year after the onset of MAS. It is likely that MAS develops in patients with CGD colitis independent of microbial infections.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23652865     DOI: 10.1097/MPH.0b013e31828e5dae

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  8 in total

1.  Inhibitory effects of andrographolide on activated macrophages and adjuvant-induced arthritis.

Authors:  Swati Gupta; Kamla Prasad Mishra; Shashi Bala Singh; Lilly Ganju
Journal:  Inflammopharmacology       Date:  2017-07-22       Impact factor: 4.473

2.  The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis.

Authors:  Sebastian Fn Bode; Sandra Ammann; Waleed Al-Herz; Mihaela Bataneant; Christopher C Dvorak; Stephan Gehring; Andrew Gennery; Kimberly C Gilmour; Luis I Gonzalez-Granado; Ute Groß-Wieltsch; Marianne Ifversen; Jenny Lingman-Framme; Susanne Matthes-Martin; Rolf Mesters; Isabelle Meyts; Joris M van Montfrans; Jana Pachlopnik Schmid; Sung-Yun Pai; Pere Soler-Palacin; Uta Schuermann; Volker Schuster; Markus G Seidel; Carsten Speckmann; Polina Stepensky; Karl-Walter Sykora; Bianca Tesi; Thomas Vraetz; Catherine Waruiru; Yenan T Bryceson; Despina Moshous; Kai Lehmberg; Michael B Jordan; Stephan Ehl
Journal:  Haematologica       Date:  2015-05-28       Impact factor: 9.941

Review 3.  Neonatal Manifestations of Chronic Granulomatous Disease: MAS/HLH and Necrotizing Pneumonia as Unusual Phenotypes and Review of the Literature.

Authors:  Antonio Marzollo; Francesca Conti; Andrea Finocchi; Silvia Bresolin; Linda Rossini; Beatrice Rivalta; Lucia Leonardi; Caterina Tretti; Francesca Tosato; Maria Chiriaco; Giorgiana Madalina Ursu; Cristina Tea Natalucci; Maddalena Martella; Alessandro Borghesi; Cecilia Mancini; Andrea Ciolfi; Gigliola di Matteo; Marco Tartaglia; Caterina Cancrini; Andrea Dotta; Alessandra Biffi
Journal:  J Clin Immunol       Date:  2021-10-31       Impact factor: 8.317

Review 4.  The genetics of macrophage activation syndrome.

Authors:  Grant S Schulert; Randy Q Cron
Journal:  Genes Immun       Date:  2020-04-15       Impact factor: 2.676

5.  NADPH oxidase controls neutrophilic response to sterile inflammation in mice by regulating the IL-1α/G-CSF axis.

Authors:  Juhi Bagaitkar; Nancy K Pech; Stoyan Ivanov; Anthony Austin; Melody Yue Zeng; Sabine Pallat; Guangming Huang; Gwendalyn J Randolph; Mary C Dinauer
Journal:  Blood       Date:  2015-10-06       Impact factor: 22.113

6.  High Levels of IL-18 and IFN-γ in Chronically Inflamed Tissue in Chronic Granulomatous Disease.

Authors:  Virginia Meda Spaccamela; Rocio G Valencia; Oleksandr Pastukhov; Andrea Duppenthaler; Matthias S Dettmer; Juliane Erb; Urs C Steiner; Sven Hillinger; Carsten Speckmann; Stephan Ehl; Janine Reichenbach; Ulrich Siler
Journal:  Front Immunol       Date:  2019-10-18       Impact factor: 7.561

7.  Case Report: Secondary Hemophagocytic Lymphohistiocytosis With Disseminated Infection in Chronic Granulomatous Disease-A Serious Cause of Mortality.

Authors:  Jacqueline D Squire; Stephanie N Vazquez; Angela Chan; Michele E Smith; Deepak Chellapandian; Laura Vose; Beatriz Teppa; I Celine Hanson; Ivan K Chinn; Lisa Forbes-Satter; Filiz O Seeborg; Sarah K Nicholas; Caridad A Martinez; Carl E Allen; Thomas J Connors; Prakash Satwani; Maria Shtessel; Hanadys Ale; Lenora M Noroski; Nicholas L Rider; Joshua D Milner; Jennifer W Leiding
Journal:  Front Immunol       Date:  2020-12-09       Impact factor: 7.561

Review 8.  A Review of Chronic Granulomatous Disease.

Authors:  Danielle E Arnold; Jennifer R Heimall
Journal:  Adv Ther       Date:  2017-11-22       Impact factor: 3.845

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.